tiprankstipranks
Trending News
More News >
Basel Medical Group Ltd (BMGL)
NASDAQ:BMGL
US Market

Basel Medical Group Ltd (BMGL) Financial Statements

Compare
75 Followers

Basel Medical Group Ltd Financial Overview

Basel Medical Group Ltd's market cap is currently $11.28M. The company's EPS TTM is $0.094; its P/E ratio is -1.23; Basel Medical Group Ltd is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 25Jun 24Jun 23Jun 22
Income Statement
Total RevenueS$ 11.32MS$ 10.05MS$ 9.70MS$ 10.66M
Gross ProfitS$ 8.79MS$ 7.80MS$ 7.36MS$ 8.48M
Operating IncomeS$ -2.18MS$ 2.20MS$ 2.00MS$ 2.47M
EBITDAS$ -11.12MS$ 3.11MS$ 2.93MS$ 3.28M
Net IncomeS$ -12.09MS$ 2.07MS$ 1.78MS$ 1.98M
Balance Sheet
Cash & Short-Term InvestmentsS$ 2.98MS$ 1.95MS$ 1.22MS$ 1.56M
Total AssetsS$ 16.85MS$ 16.31MS$ 15.38MS$ 16.85M
Total DebtS$ 3.42MS$ 4.29MS$ 7.21MS$ 10.15M
Net DebtS$ 440.39KS$ 2.34MS$ 6.00MS$ 8.59M
Total LiabilitiesS$ 11.99MS$ 8.75MS$ 9.89MS$ 13.14M
Stockholders' EquityS$ 4.86MS$ 7.56MS$ 5.49MS$ 3.71M
Cash Flow
Free Cash FlowS$ -4.40MS$ 2.50MS$ 2.59MS$ 2.70M
Operating Cash FlowS$ -4.34MS$ 2.51MS$ 2.60MS$ 2.79M
Investing Cash FlowS$ -11.04MS$ -7.92KS$ -6.16KS$ -88.50K
Financing Cash FlowS$ 16.91MS$ -1.77MS$ -2.94MS$ -12.92M
Currency in SGD

Basel Medical Group Ltd Earnings and Revenue History

Basel Medical Group Ltd Debt to Assets

Basel Medical Group Ltd Cash Flow

Basel Medical Group Ltd Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.